TRUP Company Profile and Key Details

TRUP has shown weak momentum, losing -14.72% over the past week and -27.23% over the past quarter, though year-to-date performance is down -16.46%. Short-term trend indicators are bullishly aligned (SMA20 -10.29%, SMA50 -18.59%, SMA200 -35.68%). The stock’s 14-day RSI is 33.37 (weak momentum), while the ATR of 1.58 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -52.94% below its high and over 7.92% above its low. Average 10-day trading volume of 328.26 thousand shares is below the 3-month average of 470.70 thousand, indicating normal recent market interest.

Trupanion, Inc. (NASDAQ:TRUP) closed at $25.65 USD, gaining $0.21 (0.83%) from the previous close of $25.44. The stock is currently mid-range between its 52-week high and low $24.32 and $57.88. With a market capitalization of about $1.11 billion, Trupanion, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~1.66). Key stats such as the average daily volume over the past year has been around 467.97 thousand shares, volume is running light vs its 52-week average. Headquartered in Seattle, WA, Trupanion, Inc. operates in the Financial Services sector and the Insurance - Specialty industry. Led by CEO Margaret Rosemary Maria Tooth, the company employs approximately 1,130 people and listed since July 18, 2014. Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia.

Trupanion, Inc. trades at a P/E ratio of 55.81, slightly above the S&P 500 average, with a price-to-sales ratio of 0.77 and a price-to-book ratio of 2.82 suggesting the stock is closer to book value. The P/FCF stands at 14.78, also below market averages.

Wall Street analysts project EPS growth of -0.75% annually over the next five years. The latest quarter delivered EPS of $0.13. The next quarter is forecast at $0.07. Next year's EPS is expected at $62.10. Analyst sentiment is neutral. Analyst rating data shows there are 4 Strong Buy ratings, 0 Buy ratings, 6 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $67.00 to $31.00. The high target offers 161.21% upside. The low target suggests 20.86% downside. The mean target is $49.20. This offers 91.81% upside. Trupanion, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended November 06, 2025, missed forecasts by -85.39%. The prior quarter beat by -833.33%. Over the last six quarters, Apple has recorded several small beats. These include -22.22% in August 08, 2024.

Trupanion, Inc. has 42.99 million shares outstanding. The public float is 33.43 million shares, elevated short interest at 19.79% of float. This equals 7.06 million shares. The short ratio is 12.58 days. Institutional investors hold 94.97% of the float. Insiders own 5.71%. RAWLINGS DARRYL holds 1.41 million shares, RUBIN HOWARD E has 227.86 thousand shares and Tooth Margaret has 150.29 thousand shares. Over the past six months, insider transactions show net selling. They sold 40.81 thousand shares across 13 transactions.

Trupanion, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $42.83. This means the shares are trading below this model’s fair value.

Trupanion, Inc. (NASDAQ:TRUP) shares are down -16.46% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Trupanion, Inc. trading at a premium to the broader market with a P/E of 55.81. Analyst sentiment is mixed, with the majority of ratings in Hold territory and a mean price target of $54.16, suggesting 111.15% upside. Our AI forecast model points to short-term weakness (-1.83% over two weeks), a medium-term fall (-3.74% over three months), and a longer-term gain (27.41% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Trupanion, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.83%, with price expected at $25.18 by April 16, 2026, within a range of $24.01 to $26.25 3-Month Outlook: Projected fall of -3.74%, reaching $24.69 by July 01, 2026, with a range of $23.20 to $26.05. 1-Year Outlook: Projected gain of 27.41%, with price at $32.68 by April 02, 2027, within a range of $28.95 to $36.83.